Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

ANG Lifesciences India Financial Results

ANG Lifesciences approved audited standalone and consolidated financial results for FY2026. The board meeting concluded with an unmodified audit opinion from statutory auditors.

Source

BSE filing, NSE: ANG. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

ANG Lifesciences India Ltd: key numbers

Share price
₹33.50
Market cap
₹43.75 Cr
Revenue (annual)
₹92.89 Cr
Net profit (annual)
₹-11.08 Cr
P/E (TTM)
-3.3×Sector 46.1×
Promoter holding
70.60%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from ANG Lifesciences India Ltd

All →

Other financial results announcements

All →